<DOC>
	<DOC>NCT01288898</DOC>
	<brief_summary>This study determined the safety of ASP1941 after a single and multiple once-daily doses for 10 days in healthy subjects. In addition, the Pharmacokinetics (PK) and Pharmacodynamics (PD) of ASP1941 were assessed.</brief_summary>
	<brief_title>Multiple Dose Escalating Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ASP1941</brief_title>
	<detailed_description />
	<criteria>Body weight between 60100kg, body mass index (BMI) between 2030 kg/m2, inclusive Fasting Plasma Glucose (FPG) &gt; 6.4 mmol/l HbA1c &gt; 6.2% Abnormal pulse of blood pressure at screening, as judged by the investigator</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>February 2011</verification_date>
	<keyword>ASP1941</keyword>
	<keyword>Diabetes Mellitus</keyword>
	<keyword>Multiple ascending doses</keyword>
	<keyword>Healthy subjects</keyword>
</DOC>